Paul R Duberstein1, Michael Chen2, Benjamin P Chapman3, Michael Hoerger4, Fahad Saeed5, Elizabeth Guancial6, Jennifer W Mack7. 1. Departments of Psychiatry, Medicine, and Family Medicine, University of Rochester Medical Center, 300 Crittenden Blvd., Rochester, NY, 14642, USA. Electronic address: Paul_Duberstein@urmc.rochester.edu. 2. Department of Public Health Sciences, University of Rochester Medical Center, 300 Crittenden Blvd., Rochester, NY, 14642, USA. Electronic address: Yufu_Chen@urmc.rochester.edu. 3. Departments of Psychiatry and Public Health Sciences, University of Rochester Medical Center, 300 Crittenden Blvd., Rochester, NY, 14642, USA. Electronic address: Ben_Chapman@urmc.rochester.edu. 4. Departments of Psychiatry, Medicine, and Psychology, Tulane University, 2007 Percival Stern Hall, New Orleans, LA, 70118, USA. Electronic address: mhoerger@tulane.edu. 5. Department of Medicine, Divisions of Nephrology and Palliative Care, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY, 14642, USA. Electronic address: Fahad_Saeed@urmc.rochester.edu. 6. Department of Medicine and Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY, 14642, USA. Electronic address: Elizabeth_Guancial@urmc.rochester.edu. 7. Department of Pediatric Oncology and Division of Population Sciences, Dana Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA; 25 Shattuck Street, Boston, MA 02115, USA.
Abstract
OBJECTIVE: Understanding socioeconomic disparities in the care of patients with incurable cancer is a high priority. We hypothesized that patients without a high school education are more likely to believe that they could be cured and we explored the role of fatalism. METHODS: We studied 977 patients with advanced, incurable cancer. Two logistic regression analyses were conducted. Model One examined the effect of education on beliefs about curability. Model Two added fatalism. RESULTS: The significant association between having less than a high school education and the belief that advanced cancer can be cured (OR=2.55; 95% CI: 1.09-5.96) in Model One was attenuated by 39% and rendered nonsignificant in Model Two. Fatalism was associated with the belief that advanced cancer can be cured. Whites were less likely to believe they could be cured than Blacks and Asians/Pacific Islanders. Beliefs about curability were not associated with income or insurance status. CONCLUSIONS: People who do not complete high school are more likely to believe that their advanced cancer is curable, in part because they are more likely to hold fatalistic worldviews. PRACTICE IMPLICATIONS: Interventions to help oncologists care for patients with fatalistic beliefs could mitigate socioeconomic disparities in end-of-life care.
OBJECTIVE: Understanding socioeconomic disparities in the care of patients with incurable cancer is a high priority. We hypothesized that patients without a high school education are more likely to believe that they could be cured and we explored the role of fatalism. METHODS: We studied 977 patients with advanced, incurable cancer. Two logistic regression analyses were conducted. Model One examined the effect of education on beliefs about curability. Model Two added fatalism. RESULTS: The significant association between having less than a high school education and the belief that advanced cancer can be cured (OR=2.55; 95% CI: 1.09-5.96) in Model One was attenuated by 39% and rendered nonsignificant in Model Two. Fatalism was associated with the belief that advanced cancer can be cured. Whites were less likely to believe they could be cured than Blacks and Asians/Pacific Islanders. Beliefs about curability were not associated with income or insurance status. CONCLUSIONS:People who do not complete high school are more likely to believe that their advanced cancer is curable, in part because they are more likely to hold fatalistic worldviews. PRACTICE IMPLICATIONS: Interventions to help oncologists care for patients with fatalistic beliefs could mitigate socioeconomic disparities in end-of-life care.
Authors: Jennifer W Mack; Anne Walling; Sydney Dy; Anna Liza M Antonio; John Adams; Nancy L Keating; Diana Tisnado Journal: Cancer Date: 2015-02-11 Impact factor: 6.860
Authors: Michelle Y Martin; Maria Pisu; Robert A Oster; Julie M Urmie; Deborah Schrag; Haiden A Huskamp; Jeannette Lee; Catarina I Kiefe; Mona N Fouad Journal: Cancer Date: 2011-04-26 Impact factor: 6.860
Authors: Lara Traeger; Sheila Cannon; Nancy L Keating; William F Pirl; Christopher Lathan; Michelle Y Martin; Yulei He; Elyse R Park Journal: J Clin Oncol Date: 2013-12-09 Impact factor: 44.544
Authors: Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag Journal: N Engl J Med Date: 2012-10-25 Impact factor: 91.245
Authors: Aileen B Chen; Angel Cronin; Jane C Weeks; Elizabeth A Chrischilles; Jennifer Malin; James A Hayman; Deborah Schrag Journal: J Clin Oncol Date: 2013-06-17 Impact factor: 44.544
Authors: Jakob D Jensen; Nick Carcioppolo; Andy J King; Courtney L Scherr; Christina L Jones; Jeff Niederdieppe Journal: Patient Educ Couns Date: 2013-10-09
Authors: Kah Poh Loh; Supriya G Mohile; Ronald M Epstein; Colin McHugh; Marie Flannery; Eva Culakova; Lianlian Lei; Megan Wells; Nikesha Gilmore; Dilip Babu; Mary I Whitehead; William Dale; Arti Hurria; Marsha Wittink; Allison Magnuson; Alison Conlin; Melanie Thomas; Jeffrey Berenberg; Paul R Duberstein Journal: Cancer Date: 2019-03-28 Impact factor: 6.860
Authors: Paul R Duberstein; Richard L Kravitz; Joshua J Fenton; Guibo Xing; Daniel J Tancredi; Michael Hoerger; Supriya G Mohile; Sally A Norton; Holly G Prigerson; Ronald M Epstein Journal: J Pain Symptom Manage Date: 2019-04-18 Impact factor: 3.612
Authors: Fahad Saeed; Michael Hoerger; Sally A Norton; Elizabeth Guancial; Ronald M Epstein; Paul R Duberstein Journal: J Pain Symptom Manage Date: 2018-03-23 Impact factor: 3.612
Authors: Kah Poh Loh; Supriya G Mohile; Jennifer L Lund; Ronald Epstein; Lianlian Lei; Eva Culakova; Colin McHugh; Megan Wells; Nikesha Gilmore; Mostafa R Mohamed; Charles Kamen; Valerie Aarne; Alison Conlin; James Bearden; Adedayo Onitilo; Marsha Wittink; William Dale; Arti Hurria; Paul Duberstein Journal: Oncologist Date: 2019-04-23
Authors: Kah Poh Loh; Huiwen Xu; Anthony Back; Paul R Duberstein; Supriya Gupta Mohile; Ronald Epstein; Colin McHugh; Heidi D Klepin; Gregory Abel; Stephanie J Lee; Areej El-Jawahri; Thomas W LeBlanc Journal: Cancer Date: 2019-12-06 Impact factor: 6.921
Authors: Brett R Curtis; Bruce L Rollman; Bea Herbeck Belnap; Kwonho Jeong; Lan Yu; Matthew E Harinstein; Dio Kavalieratos Journal: J Pain Symptom Manage Date: 2021-06-11 Impact factor: 3.612
Authors: Kah Poh Loh; Huiwen Xu; Ronald M Epstein; Supriya G Mohile; Holly G Prigerson; Sandra Plumb; Susan Ladwig; Sindhuja Kadambi; Melisa L Wong; Colin McHugh; Amy An; Kelly Trevino; Fahad Saeed; Paul R Duberstein Journal: J Pain Symptom Manage Date: 2020-02-13 Impact factor: 5.576
Authors: Fahad Saeed; Muhammad Adil Sardar; Sara N Davison; Haris Murad; Paul R Duberstein; Timothy Edward Quill Journal: Clin Nephrol Date: 2019-05 Impact factor: 0.975